HHS secretary RFK Jr. said that he would “shut the revolving door to reestablish public trust” in the department.
The hiring of a former top FDA official amplifies "revolving door" criticism at the worst possible time, STAT's Adam ...
Summit’s PD-1 bispecific antibody outperformed MSD’s Keytruda in a Phase III trial enrolling patients with lung cancer.
Pfizer on Monday named the former head of the U.S. health regulator's drug evaluation unit, Patrizia Cavazzoni, as its chief ...
Onge, Minister of Canadian Heritage, announced the appointment of Cheryl Hickman as the next chairperson of the Canada Council for the Arts for a five-year term. Ms. Hickman currently serves as a ...
Ontario's financial services regulator, FSRA, has revoked the life insurance and accident & sickness insurance agent licence of Daniel Lath (Lath) and imposed two administrative penalties in the total ...
Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, ...
President Trump also refused to promise pharma execs that he would hamstring the IRA’s drug negotiation program.
A packed audience at Sydney’s International Convention Centre for a UIA Gala event last night, heard Rachel Goldberg and Jon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback